Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01483495 · ClinicalTrials.gov registry record
Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 78
- Enrollment target
NCT01483495: Completed study, sponsored by University of California, Irvine.
NCT01483495 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01483495 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of the body.
Primary Outcome
Optical Imaging assess of Brain blood flow during surgical procedure
Interventions
- DEVICE Diffuse optical spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2011-12 |
| Est. Completion | 2011-12 |
What the finished NCT01483495 record still lists
NCT01483495 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Diffuse optical spectroscopy is the first listed.
NCT01483495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01483495 about?
NCT01483495 is a clinical study titled "Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study". The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of...
What is the current status of trial NCT01483495?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2011-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01483495?
The interventions under investigation include: Diffuse optical spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT01483495?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia